KOPRAN
Back to All Ratios
|
KOPRAN Last 5 Year EBIT Margin History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EBIT Margin(%) | 12.39 | 7.55 | 17.93 | 17.87 | 10.29 |
What is the latest EBIT Margin ratio of KOPRAN ?
Year | EBIT Margin |
---|---|
Mar2024 | 12.39 |
Mar2023 | 7.55 |
Mar2022 | 17.93 |
Mar2021 | 17.87 |
Mar2020 | 10.29 |
How is EBIT Margin of KOPRAN Trending?
Years | EBIT Margin | % Change | |
---|---|---|---|
Mar2024 | 12.39 | 64.11 | |
Mar2023 | 7.55 | -57.89 | |
Mar2022 | 17.93 | 0.34 | |
Mar2021 | 17.87 | 73.66 | |
Mar2020 | 10.29 | - |
Other Financial Ratios of KOPRAN
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EBIT Margin ratio of peers of KOPRAN
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
KOPRAN | ₹1,477.8 Cr | 5.4% | 3.7% | 37.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹434,604.0 Cr | 0.1% | -4% | 52.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹157,639.0 Cr | 0.7% | -0% | 70.9% | Stock Analytics | |
CIPLA | ₹128,549.0 Cr | 0.5% | -1.7% | 29.4% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,956.0 Cr | 1.1% | -2.6% | 19.2% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,468.9 Cr | -3.6% | -8.4% | 62.9% | Stock Analytics |
KOPRAN Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
KOPRAN | 5.4% |
3.7% |
37.4% |
SENSEX | -0.3% |
-2.4% |
22.4% |
You may also like the below Video Courses